Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Frovatriptan
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Alberta Health services
Deal Size : Inapplicable
Deal Type : Inapplicable
Frovatriptan as a Transitional Therapy in Medication Overuse Headache
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 07, 2010
Lead Product(s) : Frovatriptan
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Alberta Health services
Deal Size : Inapplicable
Deal Type : Inapplicable